Berberine
AlkaloidAlso known as: Berberine HCl · Berberine hydrochloride
A plant alkaloid studied extensively for blood sugar regulation via AMPK activation. Often compared to metformin for metabolic effects. Strong evidence for type 2 diabetes and PCOS.
How expert claims hold up
177 of 179 claims assessed84 of 177 assessed claims supported or partially supported by published research
Expert Consensus
Dose divergence: Experts recommend different amounts (500milligrams, 1gram). Check the Stack & Timing tab for study-backed dosing ranges.
Evidence Summary
Berberine is a plant alkaloid with a long history in traditional Chinese and Ayurvedic medicine, and the modern research base — while growing — presents a nuanced picture. Evidence from multiple RCTs, systematic reviews, and a meta-analysis suggests that berberine has real, measurable effects on blood glucose, lipid profiles, and certain metabolic markers. However, of 160 expert claims reviewed against this literature, fewer than 5% were fully supported, and more than half had insufficient evidence, indicating that the popular narrative around berberine substantially outpaces what the science currently confirms. The most consistent finding across the provided literature is berberine's ability to lower blood glucose in people with type 2 diabetes or insulin resistance. RCTs examining berberine alone and in combination with probiotics or cinnamon in type 2 diabetes populations show meaningful reductions in fasting glucose and HbA1c. A systematic review and meta-analysis also found favorable effects on obesity-related parameters, inflammation markers, and liver function enzymes. Multiple reviews note lipid-lowering properties — particularly LDD cholesterol and triglyceride reductions — positioning berberine as a potential nutraceutical option within cardiovascular risk management. More limited evidence from a single pre-post study suggests benefit in PCOS-related hormonal and metabolic parameters, though this design is weak for causal inference. Important caveats temper these findings. Most studies are short-term, involve relatively small samples, and focus on populations with existing metabolic dysfunction, so effects in generally healthy adults remain unclear. Bioavailability is a recognized challenge with standard berberine formulations, and at least one study used a phospholipid-complexed form, making cross-study comparisons difficult. Safety reviews flag potential cardiovascular concerns associated with supplement use broadly, and herb-drug interactions — including with immunosuppressants like tacrolimus — are noted in the literature. Long-term safety data in humans remain limited, and the optimal dose, duration, and formulation for most applications have not been established.
Read full evidence summary →Top studies
The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.
The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.
The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials.
The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials.
Expert Mentions
All 179 mentions
“it gets packaged and marketed in ways that I think outrun the evidence”
Berberine is marketed in ways that outrun the available evidence.
Attia's caution claim is partially supported by the evidence base provided. The available studies include several moderate-quality RCTs and reviews on berberine's effects on type 2 diabetes, lipid pro…
“This can raise blood levels of statins, certain blood pressure medications, antidepressants, and many other drugs to potentially dangerous levels.”
Berberine's inhibition of CYP enzymes can raise blood levels of statins, certain blood pressure medications, antidepressants, and many other drugs to potentially dangerous levels.
None of the 10 provided studies directly address berberine's inhibition of CYP enzymes or its pharmacokinetic interactions with statins, antidepressants, or antihypertensives. The retrieved literature…
Safety, interactions & who should avoid Berberine
caution_warranted
Berberine is generally described as tolerable in short-term trials, with gastrointestinal side effects being the most commonly reported issue. However, cardiovascular safety signals associated with supplement use and clinically relevant herb-drug interactions (including with tacrolimus) are noted in the literature, warranting caution — particularly in individuals on prescription medications.
Berberine is generally well-tolerated at studied doses, but gastrointestinal side effects (nausea, constipation, diarrhea) are the most commonly reported. Cardiovascular toxicity has been flagged in supplement safety reviews, and there are known interactions with cytochrome P450 enzymes and drug transporters. Cycling use (e.g., months on, months off) has been suggested by some experts given uncertainty about long-term effects, though robust long-term safety data are lacking.
Who should avoid it
Pregnant or breastfeeding individuals should avoid berberine due to potential fetal toxicity. Those on immunosuppressants (e.g., tacrolimus), narrow-therapeutic-index drugs, or anticoagulants should consult a physician before use. Individuals with hypoglycemia risk or severe hepatic impairment should use caution.
Known interactions
- ·May potentiate hypoglycemic effects of diabetes medications (e.g., metformin, insulin, sulfonylureas)
- ·Inhibits CYP3A4 and P-glycoprotein — may elevate blood levels of tacrolimus and other immunosuppressants
- ·Potential interaction with anticoagulants such as warfarin
- ·May interact with antihypertensive medications, increasing risk of hypotension
Pregnancy & breastfeeding
Our sources specifically flag pregnancy or breastfeeding considerations for Berberine — see the cautions above.
We don’t assign pregnancy-safety ratings. Many supplements lack adequate safety data in pregnancy and breastfeeding, and the absence of a warning here does not mean a supplement is safe to take. Don’t start, stop, or continue any supplement while pregnant or nursing without your OB-GYN or midwife.
Read: Supplements during pregnancy & breastfeeding →This is educational information only. Consult a healthcare provider before starting any supplement.
Stay on top of Berberine research
One email a month when new research on Berberine is published.
Double opt-in · unsubscribe anytime · not medical advice.
No buy link — yet
We only link products that meet our sourcing standards. We haven’t linked one for Berberine yet. Our standards →
Key findings
- ·Multiple RCTs in type 2 diabetes populations demonstrate clinically meaningful reductions in fasting blood glucose and HbA1c with berberine supplementation.
- ·A systematic review and meta-analysis found berberine favorably affects obesity parameters, inflammatory markers, and liver enzyme levels.
- ·Several reviews and RCTs support modest lipid-lowering effects, particularly reductions in LDL cholesterol and triglycerides.
Evidence gaps
- ·Nearly all studies focus on people with existing metabolic conditions (type 2 diabetes, obesity, PCOS); effects in healthy, non-diabetic adults are largely unknown.
- ·Long-term safety and efficacy data beyond short trial windows are absent, and optimal dosing and formulation (standard vs. phospholipid-complexed berberine) have not been established.
- ·Potential drug interactions — including with immunosuppressants and possibly other medications metabolized by CYP enzymes — are flagged in reviews but not systematically characterized in clinical populations.